Global Nutrigenomics Market Set To Mark 16.3% CAGR
The latest market report published by Credence Research, Inc. “Global Nutrigenomics Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global nutrigenomics market is expected to grow at a CAGR of 16.3% from 2018 to 2026.
Market Insights
Nutrigenomics is a branch of medical science where in the chronic disease are studied at genome level and nutritious diet is recommended for its treatment accordingly. There are no regulatory sanctions against any reagents and kits pertaining to nutrigenomics market. However ambiguity still persists regarding the ethical issues related to disclosure of genetic information of consumers through healthcare providers and clinical laboratories.
Browse the full report Nutrigenomics Market 2018 – 2026 report at https://www.credenceresearch.com/report/nutrigenomics-market
Reagents and kits are reigning the product segment for nutrigenomics market. The key attributes responsible for its dominance are rampant growth in clinical laboratories worldwide and rising prevalence of chronic diseases such as obesity, diabetes, cardiovascular complication and cancer. Services segment is going to register impressive growth on account of technical innovations in IT healthcare services and apps. Mandatory generation of Electronic Health Record (EHR) of patients have given an impetus to the services segment.
Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59477
As per the latest statistics provided by World Health Organization (WHO) in 2016, approximately 1.9 billion adults were reported overweight. The factors for this rampant growth in obesity are craving for junk food, sedentary lifestyle and leptin resistance. Chronic diseases will be responsible for three-fourths of the global mortality by 2020. Chronic diseases are being studied at genetic level to understand their etiology and how it can be reversed by nutritional science.
Currently saliva and buccal swabs are together dominating the test segment for nutrigenomics market. Consumers show a great inclination towards the oral sample collection method due to its inherent advantageous features such as quick, ease of collection, o pain and venipuncture associated with sample collection. Researchers are diligently working to address the bacterial contamination issue which destabilizes the DNA collected in oral samples. Other DNA collection methods such as hair and urine are being the cynosure of clinical research on account of factors such as less sample volume required, excellent storage and DNA quantification by techniques such as PCR.
North America is leading the regional segment for nutrigenomics market. Rising prevalence of chronic disease and rampant growth in the number of clinical laboratories drive the nutrigenomics market growth in North America. In Europe the government healthcare agencies have invested huge funds in academia research actively engaged in nutrigenomics studies. Increasing public health awareness also have a positive impact on the nutrigenomics market growth in North America. Asia Pacific is a potential market for key players associated with nutrigenomics to establish clinical laboratories and retail outlets. Untapped market in rural areas has a constructive effect on the nutrigenomics market growth in Asia Pacific.
Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59477
Pharmaceutical companies providing reagents and kits to determine the nutrigenomics of human beings are Cura Integrative Medicine, Centogene, Genomix Nutrition, Inc., Metagenics, Inc., NutraGene, Nutrigenomix, Navigenics, XCODE Life Sciences, Pvt. Ltd., WellGen, Inc. and 23&Me, Inc.
Key Market Movements:
Rampant growth of clinical laboratories and increasing number of people suffering with chronic disease worldwide
Technical innovation in the IT healthcare services provided and availability of low cost reagent and test kits
Paradigm shift in the approach to treat lifestyle disorder analyzing disease etiology at genetic level and recommending nutrition respectively
TOC :
Chapter 3. Nutrigenomics Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Nutrigenomics Market, by Key Players, 2017
Chapter 4. Global Nutrigenomics Market, by Product
4.1. Overview
4.2. Services
4.3. Reagents and Kits
Chapter 5. Global Nutrigenomics Market, by Application
5.1. Overview
5.2. Diabetes
5.3. Obesity
5.4. Chronic Diseases
5.5. Others
Chapter 6. Global Nutrigenomics Market, by Test
6.1. Overview
6.2. Saliva Test
6.3. Buccal Swab Test
6.4. Blood Test
6.5. Others
Chapter 7. Global Nutrigenomics Market, by Geography
7.1. Overview
7.2. North America Nutrigenomics Market Analysis, 2016 – 2026
7.2.1. North America Nutrigenomics Market, by Product, 2016 – 2026 (US$ Mn)
7.2.2. North America Nutrigenomics Market, by Application, 2016 – 2026 (US$ Mn)
7.2.3. North America Nutrigenomics Market, by Test, 2016 – 2026 (US$ Mn)
7.2.4. North America Nutrigenomics Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
Chapter 8. Company Profiles
8.1. Cura Integrative Medicine
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Centogene
8.3. Genomix Nutrition, Inc.
8.4. Metagenics, Inc.
8.5. NutraGene
8.6. Nutrigenomix
8.7. Navigenics
8.8. XCODE Life Sciences Pvt. Ltd.
8.9. WellGen, Inc.
8.10. 23&Me, Inc.
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Credence Research Inc
Name: Chris Smith (Global Sales Manager)
E-mail: [email protected]
Ph: 1-800-361-8290